Vol. 46 No. 5 (2007): Acta Oncologica

Articles

• Forty years experience of treating cancer of unknown primary

  Nicholas Pavlidis

  592-601

  Published: 2007-01-01

  • PDF

• Time patterns of changes in biomarkers, symptoms and histopathology during pelvic radiotherapy

  Annette Larsen, Benedikte Bjørge, Beate Klementsen, Lars Helgeland, Tore Wentzel-Larsen, Magne K. Fagerhol, Nils Hovdenak, Olav Dahl

  639-650

  Published: 2007-01-01

  • PDF

• Serum VEGF-C is associated with metastatic site in patients with malignant melanoma

  Pia P. Vihinen, Johanna Hilli, Meri-Sisko Vuoristo, Kari J. Syrjänen, Veli-Matti Kähäri, Seppo O. Pyrhönen

  678-684

  Published: 2007-01-01

  • PDF

• Anthracycline-induced chronic cardiotoxicity and heart failure

  Jon M. Appel, Dorte Nielsen, Bo Zerahn, Benny V. Jensen, Knud Skagen

  576-580

  Published: 2007-01-01

  • PDF

• Time-targeted therapy (TTT): Proof of principle using doxorubicin and radiation in a cultured cell system

  Yonggang Zhang, Jerry R. Williams

  621-627

  Published: 2007-01-01

  • PDF

• Osteonecrosis of the jaw in prostate cancer patients with bone metastases treated with zoledronate: A retrospective analysis

  Cinzia Ortega, Filippo Montemurro Appel, Roberto Faggiuolo, Roberto Vormola, Daniela Nanni, Franco Goia, Marco Ottavio Gilardino, Massimo Aglietta

  664-668

  Published: 2007-01-01

  • PDF

• Cetuximab and irinotecan as third line therapy in patients with advanced colorectal cancer after failure of irinotecan, oxaliplatin and 5-fluorouracil

  Per Pfeiffer, Dorte Nielsen, Mette Yilmaz, Anja Iversen , Christian Vejlø, Benny Vittrup Jensen

  697-701

  Published: 2007-01-01

  • PDF

• Radiobiological responses for two cell lines following continuous low dose-rate (CLDR) and pulsed dose rate (PDR) brachytherapy

  Per Henrik Hanisch, Torbjørn Furre, Dag Rune Olsen, Erik O. Pettersen

  602-611

  Published: 2007-01-01

  • PDF

• Expression microarray analysis reveals genes associated with in vitro resistance to cisplatin in a cell line model

  Mark B. Watson, Michael J. Lind, Laura Smith, Philip J. Drew, Lynn Cawkwell

  651-658

  Published: 2007-01-01

  • PDF

• Whole body positron emission tomography in follow-up of high risk melanoma

  Ilkka O. Koskivuo, Marko P. Seppänen, Erkki A. Suominen, Heikki R. I. Minn

  685-690

  Published: 2007-01-01

  • PDF

• The use of bisphosphonates in cancer patients

  Shenhong Wu, William L. Dahut, James L. Gulley

  581-591

  Published: 2007-01-01

  • PDF

• Human tumor cells segregate into radiosensitivity groups that associate with ATM and TP53 status

  Jerry R. Williams, Yonggang Zhang, James Russell, Cameron Koch, John B. Little

  628-638

  Published: 2007-01-01

  • PDF

• The in vitro anti-tumour activity of zoledronic acid and docetaxel at clinically achievable concentrations in prostate cancer

  Claire Morgan, Paul D. Lewis, Rachel M. Jones, Gianfilippo Bertelli, Gerry A. Thomas, Robert C. F. Leonard

  669-677

  Published: 2007-01-01

  • PDF

• Bisphosphonate induced osteonecrosis of the jaws: Unravelling uncertainty in disease causality

  Fergal C. Kelleher, Malachi McKenna, Conor Collins, Garrett Brady, Ian Collins, John Crown

  702-704

  Published: 2007-01-01

  • PDF

• Simultaneous alteration of de novo and salvage pathway to the deoxynucleoside triphosphate pool by (E)-2′-Deoxy-(fluoromethylene)cytidine (FMdC) and zidovudine (AZT) results in increased radiosensitivity in vitro

  Philippe A. Coucke, Eliane Cottin, Laurent A. Decosterd

  612-620

  Published: 2007-01-01

  • PDF

• Barriers to palliative radiotherapy referral: A Canadian perspective

  Rajiv S. Samant, Edward Fitzgibbon, Joanne Meng, Ian D. Graham

  659-663

  Published: 2007-01-01

  • PDF

• Sentinel lymph node biopsy technique and multifocal breast cancer – The Aarhus experience

  Anders Husted Madsen, Mette Cathrine Lauridsen, Jens Peter Garne, Annemette Iversen, Anders Lernevall, Line Buhl, Peer Christiansen

  691-696

  Published: 2007-01-01

  • PDF